【The Role of Cardiologists and Other Cardiovascular Healthcare Professionals in Tobacco Control 】
Please check😄➡
https://t.co/M20EEIKYJY
#WHF#Cardiovascular#health
📣 Today @worldheartfed is launching a 🆕 Policy Brief which challenges the idea that drinking moderate amounts of #alcohol can be good for the ❤️ and calls for urgent action to tackle the unprecedented global rise in alcohol-related deaths. Learn more 👉 https://t.co/54EwgkvLwc
📢【E-Cigarettes: A New Threat to Cardiovascular Health - Launched】
The WHF Policy Brief, E-Cigarettes: A New Threat to Cardiovascular Health, has been launched in 18 October❗️
https://t.co/5s19Ph6woI
📣 Today we are launching a 🆕 Policy Brief, which highlights the need for stricter regulation & greater oversight of #ecigarette sales & marketing. We must take urgent action to protect new generations & stop the e-cigarette epidemic in its tracks ➡️ https://t.co/lH7kLIpDl2
On the night of 1st October, 2021, the World Heritage Site NIJO Castle(Kyoto, JAPAN) illuminated in red to celebrate World Heart Day❤️
We use heart to create a healthy society🥰
世界心臓の日を記念して、ポスターを作成しました!
#WorldHeartDay#世��心臓の日 #UseHeart ❤️ #JCVA #WHF
#WorldHeartDay is in 2 weeks.
We want to harness the power of #digitalhealth to ensure that everyone, everywhere can access the tools they need to beat 💔
Hear more from #WHF President Prof Fausto Pinto @fjpinto1960 about what we want to achieve on 29 September.
【Announcement of Webinar】
"Cardiovascular Prevention During and After the COVID-19 Pandemic"
February 16 (Tue) Argentina 8AM~, Romania 1PM~, Singapore/Mongol 7PM~, Japan 8PM~
Speaker 3. Sun Yihong (Beijing, China) “Gender-specific Prognosis in Acute Myocardial Infarction”
Panelist 1. Alberto J. Lorenzatti (Córdoba, Argentina)
Panelist 2. Koji Hasegawa (Kyoto, Japan)
Panelist
Koji Hasegawa, President, Japan Cardiovascular Association
National Hospital Organization Kyoto Medical Center
Clinical Professor, Faculty of Medicine, Kyoto University
Discussion https://t.co/7bM6F8ZJ8u
《CVCT/JCVA virtual joint symposium in Asia ”New perspectives in the treatment of HFpEF”》
Chair
Takanori Ikeda, Chief Professor, Toho University Graduate School of Medicine, Tokyo Vice President, Japan Cardiovascular Association
Ali OTO, Vice President, Heart and Health Foundation of Turkey
Professor of Cardiology, Chairman, Department of Cardiology, MHG, Memorial
Ankara Hospital, Ankara
"Interaction between Atrial Fibrillation and HFpEF"
https://t.co/yGIgZN7aJY
Speakers
Faiez Zannad, Chairman CardioVascular Clinical Trialists Forum
Emeritus Professor, Université de Lorraine Therapeutics and Cardiology
Centre d'Investigation Clinique Inserm and CHU Nancy, France
"Clinical Trials on HFpEF"
https://t.co/a1RdlZin8Q